Compare CTSO & ONDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CTSO | ONDS |
|---|---|---|
| Founded | 1997 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.3M | 4.8B |
| IPO Year | 2008 | 2015 |
| Metric | CTSO | ONDS |
|---|---|---|
| Price | $0.40 | $7.51 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | $5.38 | ★ $19.83 |
| AVG Volume (30 Days) | 250.4K | ★ 54.9M |
| Earning Date | 05-01-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 65.79 | N/A |
| EPS | N/A | ★ 0.56 |
| Revenue | $22,503,908.00 | ★ $50,731,000.00 |
| Revenue This Year | $10.34 | $662.14 |
| Revenue Next Year | $22.41 | $76.37 |
| P/E Ratio | ★ N/A | $13.94 |
| Revenue Growth | 48.53 | ★ 605.31 |
| 52 Week Low | $0.35 | $1.78 |
| 52 Week High | $1.22 | $15.28 |
| Indicator | CTSO | ONDS |
|---|---|---|
| Relative Strength Index (RSI) | 47.52 | 36.70 |
| Support Level | $0.36 | $7.46 |
| Resistance Level | $0.74 | $8.32 |
| Average True Range (ATR) | 0.06 | 0.61 |
| MACD | 0.00 | -0.10 |
| Stochastic Oscillator | 29.28 | 7.61 |
CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.
Ondas Inc designs, develops, manufactures, sells, and supports FullMAX Software Defined Radio (SDR) technology in the United States, Israel, and India. The company operates in two business segments namely Ondas Networks and Ondas Autonomous Systems. The company generates maximum revenue from Ondas Autonomous Systems through the sales of the Optimus system and separately priced support, maintenance, and ancillary services related to the sale of the Optimus system. Geographically, the company operates in Israel, Germany, United Arab Emirates, United States, and Other Countries. It derives maximum revenue from Israel.